HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (70) Citing Articles via Google Scholar Google Scholar Articles by Schwabe, R. F. Articles by Brenner, D. A. Search for Related Content PubMed PubMed Citation Articles by Schwabe, R. F. Articles by Brenner, D. A.

THEMES

Mechanisms of Liver Injury. I. TNF--induced liver injury: role of IKK, JNK, and ROS pathways

Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York

TNF- activates several intracellular pathways to regulate inflammation, cell death, and proliferation. In the liver, TNF- is not only a mediator of hepatotoxicity but also contributes to the restoration of functional liver mass by driving hepatocyte proliferation and liver regeneration. This review summarizes recent advances in TNF- signaling mechanisms that demonstrate how the IKK, ROS, and JNK pathways interact with each other to regulate hepatocyte apoptosis and proliferation. Activation of these pathways is causatively linked to liver injury induced by concanavalin A, TNF-, and ischemia-reperfusion and to liver regeneration and hepatocarcinogenesis. In light of recent findings, pharmacological inhibitors of JNK and IKK and antioxidants may be promising new tools for the treatment of hepatitis, ischemia-reperfusion injury, and hepatocellular carcinoma.

hepatocyte; reactive oxygen species; c-Jun NH₂-terminal kinase; IB kinase

This article has been cited by other articles:

				M. Nomura, H. Ishii, A. Kawakami, and M. Yoshida Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1030 - E1038. [Abstract] [Full Text] [PDF]

				W. Zou, K. M. Beggs, E. M. Sparkenbaugh, A. D. Jones, H. S. Younis, R. A. Roth, and P. E. Ganey Sulindac Metabolism and Synergy with Tumor Necrosis Factor-{alpha} in a Drug-Inflammation Interaction Model of Idiosyncratic Liver Injury J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 114 - 121. [Abstract] [Full Text] [PDF]

				P. J. Shaw, K. M. Beggs, E. M. Sparkenbaugh, C. M. Dugan, P. E. Ganey, and R. A. Roth Trovafloxacin Enhances TNF-Induced Inflammatory Stress and Cell Death Signaling and Reduces TNF Clearance in a Murine Model of Idiosyncratic Hepatotoxicity Toxicol. Sci., October 1, 2009; 111(2): 288 - 301. [Abstract] [Full Text] [PDF]

				X. Deng, J. P. Luyendyk, P. E. Ganey, and R. A. Roth Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models Pharmacol. Rev., September 1, 2009; 61(3): 262 - 282. [Abstract] [Full Text] [PDF]

				A. Sommerfeld, R. Reinehr, and D. Haussinger Bile Acid-induced Epidermal Growth Factor Receptor Activation in Quiescent Rat Hepatic Stellate Cells Can Trigger Both Proliferation and Apoptosis J. Biol. Chem., August 14, 2009; 284(33): 22173 - 22183. [Abstract] [Full Text] [PDF]

				P. J. Shaw, P. E. Ganey, and R. A. Roth Tumor Necrosis Factor{alpha} Is a Proximal Mediator of Synergistic Hepatotoxicity from Trovafloxacin/Lipopolysaccharide Coexposure J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 62 - 68. [Abstract] [Full Text] [PDF]

				S. Dasarathy Inflammation and Liver JPEN J Parenter Enteral Nutr, November 1, 2008; 32(6): 660 - 666. [Full Text] [PDF]

				Z. Zhong, V. K. Ramshesh, H. Rehman, R. T. Currin, V. Sridharan, T. P. Theruvath, I. Kim, G. L. Wright, and J. J. Lemasters Activation of the oxygen-sensing signal cascade prevents mitochondrial injury after mouse liver ischemia-reperfusion Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G823 - G832. [Abstract] [Full Text] [PDF]

				H.-M. Ni, X. Chen, W.-X. Ding, M. Schuchmann, and X.-M. Yin Differential Roles of JNK in ConA/GalN and ConA-Induced Liver Injury in Mice Am. J. Pathol., October 1, 2008; 173(4): 962 - 972. [Abstract] [Full Text] [PDF]

				N. Anderson and J. Borlak Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357. [Abstract] [Full Text] [PDF]

				N. Kumashiro, Y. Tamura, T. Uchida, T. Ogihara, Y. Fujitani, T. Hirose, H. Mochizuki, R. Kawamori, and H. Watada Impact of Oxidative Stress and Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1{alpha} in Hepatic Insulin Resistance Diabetes, August 1, 2008; 57(8): 2083 - 2091. [Abstract] [Full Text] [PDF]

				O. Sanchez, M. Viladrich, I. Ramirez, and M. Soley Liver injury after an aggressive encounter in male mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R1908 - R1916. [Abstract] [Full Text] [PDF]

				M. Iniguez, C. Berasain, E. Martinez-Anso, M. Bustos, P. Fortes, D. Pennica, M. A. Avila, and J. Prieto Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning J. Exp. Med., December 25, 2006; 203(13): 2809 - 2815. [Abstract] [Full Text] [PDF]

				E. K. Lobenhofer, G. A. Boorman, K. L. Phillips, A. N. Heinloth, D. E. Malarkey, P. E. Blackshear, C. Houle, and P. Hurban Application of Visualization Tools to the Analysis of Histopathological Data Enhances Biological Insight and Interpretation Toxicol Pathol, December 1, 2006; 34(7): 921 - 928. [Abstract] [Full Text] [PDF]